Caffeine/Ibuprofen

咖啡因/布洛芬

Report date: 2026/03/23 20:03:44

Base Information

Drug NameCaffeine/Ibuprofen
Drug Alias NameCaffeine+Ibuprofen咖啡因+布洛芬Ibuprofen+Caffeine布洛芬+咖啡因Ibuprofen/Caffeine +[6] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists
TargetsAdenosine A1 receptorAdenosine A2a receptorCyclooxygenases
Therapy Area/IndicationsNeck PainBack PainPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRussian FederationSouth Africa +[4] 
CombinationsYes IbuprofenCaffeine
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgPfizer Inc
Active IndicationsN/A
Inactive IndicationsNeck PainBack PainPain

Other Information

ATC CodeN/A
Related LinksN/A